baber/WOPTO huggingface dataset:
Patent EP-4163271-A1 (EP)
Inventor: HU HAIWEN
IPC: C07D213/24
Filed: 2021-05-26
Abstract: The invention provides a method for preparing a key intermediate for the synthesis of (S)-2-(3S,8S)-3-(4-(3,4-dichlorobenzyloxy)phenyl-7-((S)-1-phenylpropyl)-2,3,6,7,8,9-hexahydro-[1,4]-dioxino[2,3-g]isoquinolin-8-ylformylamino)-3-(4-(2,3-dim ethylpyridin-4-yl)phenyl)propionic acid dihydrochloride: methyl (S)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenylpropionate and the salt thereof. The method adopts continuous feeding mode, does not require column chromatographic purification, simplifies the procedures, reduces loss and increases yield. Furthermore, the product, i.e., salt of methyl (S)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenylpropionate, obtained by the purification mode of salt formation, has high purity and good storage stability. The preparation method of the invention can achieve a total yield of above 85%, a purity of the target product of above 98%, and a content of the isomer of below 0.5%. In addition, the method of the invention has good process stability, can produce quality-controlled product, and can be applied to industrial production.
Patent EP-4247291-A1 (EP)
Inventor: GIULIANOTTI PIER CRISTOFORO
IPC: A61B34/37
Filed: 2021-11-09
Abstract: A robotic surgical station (1), comprising: ■ a wheeled base (100) configured to be rested on the ground; ■ a partial-ring shaped structure (210) slidably coupled to the based (210) to be rotatable relative to the base (100) about a horizontal roll axis (R) passing through a center (C) of the ring shape; ■ a patient's bed (600) restrained to a first arcuate segment (211) of the partial-ring shaped structure (210) at a first mount (220); * a plurality of robotic arms (900) restrained to a second arcuate segment (212) of the partial-ring shaped structure (210) at a second mount (250); and ■ a remote control unit (801) that may be used by a surgeon to command one or more of said plurality of robotic arms (900), wherein the second arcuate segment (212) is rotatable sideways with respect to the first arcuate segment (211) in such a way to allow full access to the patient's bed (600) by a surgeon.
Patent EP-4255560-A1 (EP)
Inventor: PÄTILÄ TOMMI
IPC: A61N5/06
Filed: 2021-12-02
Abstract: Kit et un procédé de traitement de patients affectés de syndrome de sécheresse buccale. Le kit comprend un embout buccal odontologique qui présente une ou plusieurs sources de lumière pour produire de la lumière dans la plage du proche infrarouge et qui, une fois placé dans la cavité buccale, peut diriger la lumière vers le tissu cible sélectionné parmi les glandes salivaires, les glandes sous-mandibulaires ou les deux, pour l'utilisation dans le traitement de patients affectés de syndrome de sécheresse buccale. Le kit et le procédé peuvent être utilisés pour traiter le syndrome de Sjögren, des patients type polypharmacie, des patients diabétiques ou des patients ayant un nombre réduit de glandes salivaires en particulier causant une baisse marquée, temporaire ou permanente de la production de salive.
Patent EP-4168023-A1 (EP)
Inventor: MCQUEEN ADAM
IPC: A61L27/36
Filed: 2021-06-17
Abstract: A meshed, dehydrated, umbilical tissue allograft that can be used in the treatment of wounds. Specifically, the meshed allograft has the property of being able to be expanded to cover an irregularly shaped wound, therefore reducing the need to apply multiple, uniform sized grafts to a single wound site. The meshed, dehydrated umbilical tissue allograft is sourced from a human donor, and is then processed to remove any potential contaminants or microbes prior to applying a specific mesh pattern to the tissue. The meshed, dehydrated, umbilical tissue graft is reconstituted prior to applying to the subject, and can then be configured to optimally cover the shape of the wound site.
Patent EP-4177249-A1 (EP)
Inventor: LI JIN
IPC: C07D413/12
Filed: 2021-04-15
Abstract: Disclosed herein is an immunomodulator, and an application thereof in the preparation of drugs. The IL-17A-inhibiting compound is represented by formula (I) or a stereisomer thereof, providing a new possibility to clinically select and/or prepare medicines for diseases associated with IL-17A activity.
Patent EP-4262722-A1 (EP)
Inventor: NICOU VALÉRIE
IPC: A61K8/41
Filed: 2021-12-16
Abstract: The invention relates to a composition comprising at least one oxidation coupler chosen from hydroxyethyl-3,4-methylenedioxyaniline of formula (I), one of its addition salts, its solvates and/or the solvates of its salts, at least one oxidation coupler chosen from 2-amino-5-ethylphenol of formula (II), one of its addition salts, its solvates and/or the solvates of its salts, and at least one oxyethylenated C 8 -C 30  fatty acid ester of sorbitan having from 1 to 10 ethylene oxide units. The invention also relates to a process for dyeing keratin fibres, preferably the hair, comprising the application of the composition to said keratin fibres.
Patent EP-4179018-A1 (EP)
Title: Conversion of plastics to monomers by pyrolysis
Inventor: BARGER PAUL T
IPC: B29B17/02
Filed: 2021-07-08
Abstract: A plastic pyrolysis process that can produce high yields of ethylene, propylene and other light olefins from waste plastics is disclosed. The plastic feed is pyrolyzed at a low-temperature pyrolysis process and subsequently pyrolyzed in a high-temperature pyrolysis process directly to monomers, such as ethylene and propylene. Insufficiently pyrolyzed product from the low-temperature pyrolysis process can be fed to the high-temperature pyrolysis process while preserving the desired low-temperature product monomers.
Patent EP-4272255-A1 (EP)
Title: Solar cell
Inventor: TANG MUZHI
IPC: H01L31/0216
Filed: 2021-12-20
Abstract: A solar cell comprising a substrate having a front surface configured to face a light source in use, and a rear surface opposite the front surface. The front surface has a front surface morphology and the rear surface has a rear surface morphology. The front and rear surface morphologies are configured such that the front surface has a greater surface area than the rear surface. The solar cell also includes an emitter arranged on the rear surface of the substrate. Also disclosed is a method of forming a layered structure of a solar cell, which includes performing finishing processes such that a first (e.g. front) surface of a substrate has a greater surface area than a second (e.g. rear) surface. The method further includes providing a reflector layer that may be tuned to the morphology of the second surface.
Patent EP-4267953-A1 (EP)
Title: Isolation d'interférences en mesure d'alcalinité
Inventor: SALZER COREY ALAN
IPC: G01N31/16
Filed: 2021-12-17
Abstract: Selon l'invention, un mode de réalisation concerne un procédé pour la mesure d'une caractéristique d'un échantillon aqueux, consistant à : introduire l'échantillon aqueux dans une région de titrage et une région de réaction d'un dispositif de mesure, la région de titrage comprenant une électrode de pH et une électrode de protonation en contact avec une première partie d'un échantillon aqueux, la région de réaction comprenant une contre-électrode en contact avec une seconde partie de l'échantillon aqueux ; placer un réservoir d'électrolyte dans un état de continuité électrique avec la région de titrage et la région de réaction, le réservoir d'électrolyte comprenant une électrode de référence, le volume du réservoir d'électrolyte comprenant un grand volume d'un électrolyte ; et déterminer une caractéristique de l'échantillon aqueux par la mesure d'une caractéristique électrochimique entre l'électrode de référence et au moins l'une parmi l'électrode de pH et la contre-électrode. D'autres aspects sont décrits et revendiqués.
Patent EP-4205739-A1 (EP)
Title: Application of artemisinin compound in treatment of coronavirus infection
Inventor: CAO RUIYUAN
IPC: A61K31/366
Filed: 2021-07-22
Abstract: The present invention relates to an application of an artemisinin compound in treatment of coronavirus infection. Specifically, the present invention provides an application of the compound, and a stereoisomer, a pharmaceutically acceptable salt, a solvate or a hydrate thereof in preparation of medicines. The medicines are used for treating diseases or infection caused by coronavirus (preferably SARS-CoV-2), and the compound is selected from one or more of artemisinin, arteether, artemether, artemisia ketone, dihydroartemisinin, artesunate, arteannuin B, and artemisinic acid.
Patent EP-4199904-A1 (EP)
Title: Nano lipid carrier system for improving permeation of active ingredients
Inventor: KOCHERLAKOTA CHANDRASHEKHAR
IPC: A61K9/107
Filed: 2021-08-18
Abstract: The present invention relates to a formulation comprising a nano lipid carrier system comprising an active ingredient, low phase transition solid lipid, PEGylated lipid, surfactants and cosolvents etc, dispersed in water or aqueous medium. The hydrodynamic diameter of the nanocarrier system in aqueous media is less than about 1000nm. The present invention formulation can be in the form of a liquid (solution, suspension, dispersion), liquid filled hard gelatin capsule, soft gelatin capsule or a liquid concentrate.
Patent EP-4205469-A1 (EP)
Inventor: LIU KANGQI
IPC: H04W72/00
Filed: 2021-08-26
Abstract: Methods, systems, and devices for wireless communications are described. A user equipment (UE) may receive a downlink control information (DCI) comprising a grant scheduling a data transmission for the UE, the data transmission associated with a rateless coding scheme. The UE may determine to disable feedback information for the data transmission based at least in part on the rateless coding scheme and one or more of: the DCI, a resource associated with the DCI, or a semi-persistent scheduling configuration associated with the data transmission. The UE may perform or monitor for the data transmission according to the DCI and the rateless coding scheme. The UE may perform or monitor for the feedback information for the data transmission according to the determining.
Patent EP-4207878-A1 (EP)
Title: Terminal, base station and communication method
Inventor: TAKAHASHI HIDEAKI
IPC: H04W48/10
Filed: 2021-07-07
Abstract: A terminal includes a receiving unit that receives first system information from a base station; and a control unit that acquires, from the first system information, a first list, a second list, and a third list, the first list scheduling second system information other than the first system information, and determines, based on the second list and the third list, a start position of a window for acquiring the second system information, wherein the receiving unit receives, from the base station, the second system information in the window.
Patent EP-4208075-A1 (EP)
Inventor: BEX PETER
IPC: A61B3/024
Filed: 2021-09-07
Abstract: Methods and devices for rapid, self-administered, and adaptive testing of a wide variety of visual and neurological impairments are based on graphical presentation to a subject of visual stimuli of varying intensity. Psychometric functions are used to determine the subject's sensitivity to selected stimuli. Diagnosis of ophthalmic, optometric, and/or neurologic conditions is achieved from the subject's stimulus sensitivity pattern.
Patent EP-4181236-A1 (EP)
Title: Negative electrode active material, and negative electrode and secondary battery comprising same
Inventor: LEE CHANG JU
IPC: H01M4/02
Filed: 2021-09-15
Abstract: The present invention relates to a negative electrode active material comprising: artificial graphite particles; and sulfur (S) distributed in the artificial graphite particles, wherein the sulfur content in the negative electrode active material is 15 ppm to 40 ppm. A negative electrode and secondary battery that comprise the negative electrode active material can have both improved output characteristics and capacity characteristics, as well as improved initial efficiency.
Patent EP-4216947-A1 (EP)
Inventor: DHARMESH MAHENDRABHAI SHAH
IPC: A61K31/404
Filed: 2021-10-14
Abstract: The present invention relates to an oral soft-gelatin capsule dosage form of Nintedanib and pharmaceutically acceptable salt thereof. The invention also relates to provide patient-compliant, economical and technically advanced dosage form over existing marketed dosage form as well as nearest prior-arts. Moreover, the dissolution rate and stability of the patient compliant Nintedanib formulation, prepared as per the present invention, is proven higher when compared to prior art inventions. Furthermore, the present invention also provides an oily dispersion without using lecithin is prepared by a process which is relatively simple, easy to commercially manufacture, and functionally reproducible.
Patent EP-4084190-A1 (EP)
Title: Battery pack and automobile including same
Inventor: HONG SOON-CHANG
IPC: H01M10/6551
Filed: 2021-10-06
Abstract: A battery pack according to the present disclosure includes a first battery module; a first top cover provided on the first battery module; a second battery module mounted on top of the first battery module on the first top cover; a second top cover provided on the second battery module; an inter-top cover part as a cooling device interposed between the first top cover and the second top cover, and including a heatsink having a cooling water passage space inside, an inter-top cover part upper member in contact with an upper surface of the heatsink using a thermal resin, and a heatsink port for entry/exit of cooling water to/from the cooling water passage space; a lower gasket provided at a contact area between the first top cover and the inter-top cover part; and an upper gasket provided at a contact area between the second top cover and the inter-top cover part.
Patent EP-4122236-A1 (EP)
Title: Neighbor cell measurements
IPC: H04W36/00
Filed: 2021-05-10
Abstract: This disclosure relates to techniques for configuring, performing, and reporting neighbor cell measurements in a wireless communication system. A base station of a serving cell may provide configuration information relevant to performing layer 1 (L1) measurements based on reference signals of one or more neighbor cells. A UE may perform L1 inter-frequency measurements of the neighbor cell (s) based on the configuration. The UE may report the measurements.
Patent EP-4212342-A1 (EP)
Inventor: ETO DAISUKE
IPC: B41J2/01
Filed: 2021-10-27
Abstract: An inkjet recording device includes a conveyance unit, a carriage, ink heads, and a plurality of processing heads. The conveyance unit conveys a recording medium in a predetermined conveyance direction. The carriage reciprocates in a main scanning direction intersecting the conveyance direction. The ink heads are mounted on the carriage so as to be aligned in the main scanning direction, and eject ink for image formation. The processing heads are mounted on the carriage and eject a non-coloring processing solution. The plurality of processing heads are arranged side by side in the main scanning direction at positions different from the ink head in the conveyance direction.
Patent EP-4224901-A1 (EP)
Inventor: YAO CHUTING
IPC: H04W12/06
Filed: 2021-10-20
Abstract: This application relates to a communication method and apparatus. A first network device receives first information from a second terminal device or a third network device, where the first information includes an identifier of a first terminal device, and the third network device is a network device on which the second terminal device camps. The first network device sends the identifier of the first terminal device to a second network device, where the identifier of the first terminal device is used to determine whether the first terminal device is authorized to provide a relay service. The first network device receives second information from the second network device, where the second information is used to indicate that the first terminal device is authorized to provide a relay service, or indicate that the first terminal device is not authorized to provide a relay service. Even if the first terminal device is in an RRC non-connected state, the first network device may determine, by using the second network device, whether the first terminal device is authorized to provide a relay service, so that a network access success rate of the second terminal device can be improved.
Patent EP-4053077-A1 (EP)
Title: Aluminum-containing silica sol dispersed in nitrogen-containing solvent, and resin composition
Inventor: KUROIWA KAZUYA
IPC: C09D7/62
Filed: 2021-11-04
Abstract: There is provided a silica sol dispersed in a nitrogen-containing solvent and a silica-containing resin composition (in particular, an insulating resin composition) containing a nitrogen atom-containing polymer.A silica sol comprising silica particles containing aluminum atoms and having an average primary particle diameter of 5 to 100 nm, the silica particles being dispersed in a nitrogen-containing solvent, wherein the aluminum atoms are bonded to the surfaces of the silica particles in an amount in terms of Al<sub>2</sub>O<sub>3</sub> of 800 to 10,000 ppm/SiO<sub>2</sub>. The silica particles are bonded to a silane compound or a hydrolysate of the silane compound. The nitrogen-containing solvent is an amide solvent. The nitrogen-containing solvent is dimethylacetamide, dimethylformamide, N-methylpyrrolidone, or N-ethylpyrrolidone. The insulating resin composition comprising the silica sol and a nitrogen-containing polymer. The nitrogen-containing polymer is polyimide, polyamide, polyamic acid, polyamideimide, polyetherimide, or polyesterimide. An insulation-coated conductor wire produced by insulation coating of a conductor wire with the insulating resin composition.
Patent EP-4246830-A1 (EP)
Inventor: TANG NINGFENG
IPC: H04B10/25
Filed: 2021-09-14
Abstract: An optical fiber connection method and device, a storage medium, and an electronic device. The optical fiber connection device comprises: a first high-density optical connector, connected to a first optical interconnection unit and an external light source, and configured to gather N optical fibers connected to both the first optical interconnection unit and the external light source, and connect the gathered N optical fibers to a second high-density optical connector, K second optical interconnection units, and the external light source; and the second high-density optical connector, connected to the K second optical interconnection units by means of the first high-density optical connector.
Patent EP-4249649-A1 (EP)
Title: Lithium composite oxide single crystal, lithium composite oxide polycrystal, lithium composite oxide material, solid electrolyte material, all-solid-state lithium ion secondary battery, and method for producing solid electrolyte material
Inventor: KATAOKA KUNIMITSU
IPC: C30B29/22
Filed: 2021-11-12
Abstract: The lithium composite oxide single crystal has a chemical composition represented by Li 7-3x-w-v Ga x La 3 Zr 2-w-v TawNb v O 12  (0.02 ≤ x < 0.5, 0 ≤ W ≤ 1.0, 0 ≤ V ≤ 1.0, and 0.05 ≤ W + V ≤ 1.0), which belongs to the space group I-43d in a cubic system and has a garnet structure.
Patent EP-4243530-A1 (EP)
Inventor: LIU YUN
IPC: H04W72/04
Filed: 2021-11-30
Abstract: This application provides a data transmission method and apparatus, and relates to the field of communication technologies. In the method, a terminal receives a slot format and PUSCH parameters from a network device; determines a first resource in a first slot based on the slot format and the PUSCH parameters, where the first resource is formed by available symbols; and determines, based on a quantity of the available symbols in the first resource, whether to send a PUSCH in a frequency hopping manner in the first resource, instead of directly sending the PUSCH in the frequency hopping manner in the first resource based on a configuration of the network device, so that resource utilization can be improved.
Patent EP-4258994-A1 (EP)
Inventor: MILNER THOMAS E
IPC: A61B6/00
Filed: 2021-12-10
Abstract: Apparatus, systems and methods for fracturing calcium in an artery of a patient. Certain embodiments include an expandable member, a laser light source and an optical fiber coupled to the laser light source. The optical fiber can comprise one or more emission points configured to emit electromagnetic energy from the laser light source. The electromagnetic energy can be transmitted through a fluid in the expandable member to fracture the calcium.
Patent EP-4263690-A1 (EP)
Title: Long-term fire retardant with corrosion inhibitors and methods for making and using same
Inventor: HULBERT DENNIS
IPC: C08K3/016
Filed: 2021-12-15
Abstract: A forest fire retardant composition contains a retardant compound that includes a phosphate salt. The sulfate salt may include diammonium phosphate, diammonium orthophosphate, monoammonium phosphate, monoammonium orthophosphate, monosodium phosphate, di sodium phosphate, di sodium phosphate hydrate, sodium ammonium phosphate, sodium ammonium phosphate hydrate, sodium tripolyphosphate, tri sodium phosphate, or dipotassium phosphate, and combinations thereof. The forest fire retardant composition may include an ammonium source. The composition may be in the form of a dry concentrate, a liquid concentrate, or a final diluted product. The final diluted product is effective in suppressing, retarding, and controlling forest fires while exhibiting corrosion resistance and low toxicity.
Patent EP-4264959-A1 (EP)
Title: Subwoofer phase alignment control method and system
Inventor: ORTH SCOTT
IPC: H04R3/04
Filed: 2021-12-17
Abstract: A multi-speaker (e.g., home theater or stereo) audio system 200 with one or more subwoofers includes improved phase-adjustable subwoofers 222 and an improved subwoofer phase control method allows the user to quickly and accurately select the most satisfying subwoofer phase adjustments for blending the subwoofer's output with the remainder of the system's speakers' output.
Patent EP-4271395-A1 (EP)
Inventor: TOPORS MOURAD
IPC: A61K35/12
Filed: 2021-12-29
Abstract: Les compositions, les méthodes et les systèmes divulgués sont utiles dans le traitement et la prévention de divers cancers associés à une accumulation de cholestérol mitochondrial. Dans de nombreux modes de réalisation, les compositions, les méthodes et les systèmes divulgués peuvent améliorer l'efficacité et la cytotoxicité de composés chimiothérapeutiques, par exemple en augmentant la sensibilité cellulaire à la chimiothérapie et/ou en réduisant ou en prévenant toute résistance. Dans de nombreux modes de réalisation, le cancer peut être un carcinome hépatocellulaire de stade précoce ou tardif.
Patent EP-4278272-A1 (EP)
Inventor: GLISIC LEO
IPC: G06F15/00
Filed: 2021-12-27
Abstract: A virtual communication system including logic for supporting layered conversations, the system comprising: at least two computers communicating to one another over a communications medium, where each computer represents a User, each computer including a display, audio input, audio output, video input (such as a camera), memory, data storage, and a processor, a knowledge base stored in memory, the knowledgebase containing an identifier identifying each conversation associated with a given user, the knowledgebase storing information identifying each participant in each of the conversations, the knowledgebase storing information identifying the type of each conversation associated with the given one of the at least two computers, where each User may participate in multiple simultaneous conversations; and layered conversation logic executed by the processor, the layered conversation logic controlling a volume and a visual layout of each participant in each conversation in which the User participates in accordance with the conversation type.